Top Markets
Coin of the day
Stryker Corporation Stryker Corporation

Stryker Corporation

SYK
주식 순위 #160
Stryker Corporation operates as a medical technology company. The company... Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
주가
$336.84
시가총액
$129.13B
변동 (1일)
2.00%
변동 (1년)
-15.94%
국가
US
거래 Stryker Corporation (SYK)

카테고리

Stryker Corporation (SYK)의 P/E 비율
July 2026 기준 P/E 비율 TTM: 35.63
Stryker Corporation의 최신 재무 보고서와 주가에 따르면 현재 P/E (TTM) 비율은 35.63입니다. 2024년 말 기준 P/E 비율은 45.83였습니다.
Stryker Corporation의 P/E 비율 기록 (2000 ~ 2026)
매년 말 P/E 비율
연도 P/E 비율 변화
2026 (TTM) 35.63 -13.89%
2025 41.38 -9.71%
2024 45.83 27.61%
2023 35.92 -8.41%
2022 39.21 -22.44%
2021 50.56 -12.14%
2020 57.54 52.66%
2019 37.69 128.39%
2018 16.50 -70.93%
2017 56.77 108.63%
2016 27.21 11.88%
2015 24.32 -64.92%
2014 69.33 145.16%
2013 28.28 75.92%
2012 16.07 12.53%
2011 14.28 -14.55%
2010 16.72 -7.52%
2009 18.08 27.26%
2008 14.20 -52.79%
2007 30.09 4.28%
2006 28.85 8.62%
2005 26.56 -36.09%
2004 41.57 6.61%
2003 38.99 -3.57%
2002 40.43 -4.42%
2001 42.30 -5.53%
2000 44.78 0.00%
유사 기업 또는 경쟁사의 P/E 비율
회사 P/E 비율 P/E 비율 차이 국가
24.71 -30.65%
US
21.15 -40.65%
IE
17.76 -50.15%
US
47.67 33.77%
US
30.88 -13.33%
US
P/E 비율 읽는 방법

P/E 비율은 회사의 주가와 주당순이익 간의 관계를 측정합니다.
낮지만 양수인 P/E는 현재 가치 대비 높은 수익을 내고 있는 저평가된 기업을 의미합니다. 높은 음수(0에 가까운) P/E는 큰 손실을 나타냅니다.

P/E가 30을 초과하거나 음수인 기업은 일반적으로 '성장주'로 간주되며, 투자자들은 향후 수익성 개선을 기대합니다.

양의 P/E가 10 미만인 기업은 일반적으로 '가치주'로 간주되며, 이미 매우 수익성이 높고 향후 큰 성장은 기대되지 않습니다.